Do Sociodemographic Factors Influence Outcome in Prostate Cancer Patients Treated with External Beam Radiation Therapy?

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 39, Issue 6, 2016, Pages 563-567

  Movsas, Avielle ^a   Ibrahim, Ramy ^a   Elshaikh, Mohamed A ^a   Lamerato, Lois ^a   Lu, Mei ^a   Sitarik, Alexandra ^a   Pradhan, Deepak ^a   Walker, Eleanor M ^a   Stricker, Hans ^a   Freytag, Svend O ^a   Chetty, Indrin J ^a   Movsas, Benjamin ^a   Siddiqui, Farzan ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

income; prostate cancer; race; radiation dose; sociodemographic

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BIOCHEMICAL RECURRENCE; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL OUTCOME; DEMOGRAPHY; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HIGH RISK PATIENT; HOUSEHOLD INCOME; HUMAN; INTERMEDIATE RISK PATIENT; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTIVE VALUE; PROSTATE CANCER; RACE; RADIATION DOSE; TREATMENT OUTCOME; VERY ELDERLY; AGE; BLOOD; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; CONFORMAL RADIOTHERAPY; FOLLOW UP; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SOCIOECONOMICS; SURVIVAL ANALYSIS; TIME FACTOR; TUMOR INVASION;

AGE FACTORS; AGED; COHORT STUDIES; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84901383281     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0000000000000093     Document Type: Article

References (33)

1. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9-29. [Epub ahead of print].
2. Chornokur G, Dalton K, Borysova ME, et al. Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer. Prostate. 2011;71:985-997.
3. Horner MJ, Ries LAG, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute; 2009.
4. Ahaghotu C, Baffoe-Bonnie A, Kittles R, et al. Clinical characteristics of African-American men with hereditary prostate cancer: the AAHPC Study. Prostate Cancer Prostatic Dis. 2004;7:165-169.
5. Reddy S, Shapiro M, Morton R Jr, et al. Prostate cancer in black and white Americans. Cancer Metastasis Rev. 2003;22:83-86.
6. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280:969-974.
7. Bureau of the Census. 2000 Census of Population and Housing. PHC-2-Summary Social, Economic and Housing Characteristics, U.S. Census Bureau. 2003.
8. Kuban DA, Tucker SL, Dong L, et al. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70:67-74.
9. Peeters ST, Heemsbergen WD, Koper PC, et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol. 2006;24:1990-1996.
10. Zietman AL, Bae K, Slater JD, et al. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09. J Clin Oncol. 2010;28:1106-1111.
11. Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002;53:1097-1105.
12. Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs. high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA. 2005;294:1233-1239.
13. Abramowitz MC, Li T, Buyyounouski MK, et al. The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer. 2008;112:55-60.
14. Kuban DA, Levy LB, Cheung MR, et al. Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease? Int J Radiat Oncol Biol Phys. 2011;79:1310-1317.
15. Zelefsky MJ, Yamada Y, Fuks Z, et al. Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys. 2008;71:1028-1033.
16. Nguyen QN, Levy LB, Lee AK, et al. Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation. Cancer. 2013;119:3265-3271.
17. Pahlajani N, Ruth KJ, Buyyounouski MK, et al. Radiotherapy doses of 80 Gy and higher are associated with lower mortality in men with Gleason score 8 to 10 prostate cancer. Int J Radiat Oncol Biol Phys. 2012;82:1949-1956.
18. Albain KS, Unger JM, Crowley JJ, et al. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst. 2009;101:984-992.
19. Evans S, Metcalfe C, Ibrahim F, et al. Investigating Black-White differences in prostate cancer prognosis: a systematic review and meta-analysis. Int J Cancer. 2008;123:430-435.
20. Tewari AK, Gold HT, Demers RY, et al. Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancer. Urology. 2009;73:624-630.
21. Jani AB, Gratzle J. Analysis of impact of age and race on biochemical control after radiotherapy in different prostate cancer settings. Urology. 2005;66:124-129.
22. Du XL, Fang S, Coker AL, et al. Racial disparity and sociodemographic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer. 2006;106:1276-1285.
23. Robbins AS, Yin D, Parikh-Patel A. Differences in prognostic factors and survival among White men and Black men with prostate cancer, California, 1995-2004. Am J Epidemiol. 2007;166: 71-78.
24. Du KL, Bae K, Movsas B, et al. Impact of marital status and race on outcomes of patients enrolled in Radiation Therapy Oncology Group prostate cancer trials. Support Cancer Center. 2012;20: 1317-1325.
25. Spencer BA, Miller DC, Litwin MS, et al. Variations in quality of care for men with early-stage prostate cancer. J Clin Oncol. 2008; 26:3735-3742.
26. Klein JB, Nguyen CT, Saffore L, et al. Racial disparities in urologic health care. J Natl Med Assoc. 2010;102:108-117.
27. D'Amico AV, Manola J, Loffredo M, et al. 6-month androgen suppression plus radiation therapy vs. radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. JAMA. 2004;292:821-827.
28. Lawton CA, DeSilvio M, Roach M 3rd, et al. An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions. Int J Radiat Oncol Biol Phys. 2007;69:646-655.
29. Dash A, Lee P, Zhou Q, et al. Impact of socioeconomic factors on prostate cancer outcomes in black patients treated with surgery. Urology. 2008;72:641-646.
30. Srougi V, Antunes AA, Reis ST, et al. Socioeconomic status is an independent predictor of biochemical recurrence among patients with prostate cancer who undergo radical prostatectomy. Int Braz J Urol. 2011;37:507-513.
31. Konski AA, Pajak TF, Movsas B, et al. Disadvantage of men living alone participating in Radiation Therapy Oncology Group head and neck trials. J Clin Oncol. 2006;24:4177-4183.
32. Krongrad A, Lai H, Burke MA, et al. Marriage and mortality in prostate cancer. J Urol. 1996;156:1696-1700.
33. Bergman J, Gore JL, Saigal CS, et al. Partnership and outcomes in men with prostate cancer. Cancer. 2009;115:4688-4694.